期刊文献+

细胞周期素D_2在霍奇金淋巴瘤及间变性大细胞淋巴瘤中的表达及其意义探讨

Expression of cyclin D_2 in Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma and Its Significance
下载PDF
导出
摘要 目的 检测细胞周期素D2 (cyclinD2 )在霍奇金淋巴瘤 (HL)及间变性大细胞淋巴瘤 (ALCL)中蛋白质水平的表达情况 ,探讨其表达在HL和ALCL的发生发展中所起的作用。方法 收集 2 88例恶性淋巴瘤石蜡包埋标本 ,筛选出HL2 6例 ,ALCL19例 ,切片经微波抗原修复 ,cyclinD2 免疫组化染色 ,光学显微镜镜下计数阳性细胞。结果 cyclinD2 在HL病例组中的表达率为 92 .3% (2 4 / 2 6 ) ,在ALCL组中阳性率为 (36 .8% ) 7/ 19,两组病例的表达差异有统计学意义 (P <0 .0 5 )。结论  (1)cyclinD2 在HL和ALCL中的表达差异提示HL和ALCL在发生过程中起因不同并存在不同的生长调控机制。 (2 )cyclinD2 在HL和ALCL表达的差异对两者的鉴别诊断有帮助。 (3)HL与ALCL的细胞起源不同 ,但两者也可能存在一些重叠与过渡的形式 。 Objective To detect the expression of cyclin D 2 in HL and ALCL at the level of protein and to investigate the roles of this gene in the pathogenesis of HL and ALCL.Methods Selecting the cases of HL and ALCL from 288 cases of malignant lymphomas. The clarified 26 paraffin embed tissue, comprising cases of 26 cases of HL and 19 cases of ALCL were finally subjected to immunohistochemical staining to analyze the expression of cyclin D 2.Results The positive rate of cyclin D 2 expression in HL and in ALCL were 92.3% (24/26) and 36.8% (7/19) respectively, there presented a statistic difference between HL and ALCL groups ( P < 0.05 ).Conclusion This study reported the different expression of cyclin D 2 in protein level in HL and ALCL, high expression of cyclin D 2 was mainly shown in HL but low or negative expressed in most cases of ALCL. The expressing feature of cyclin D 2 might imply a different mechanism of oncogenesis and growth control in HL and ALCL. In a few cases, cyclin D 2 protein in neoplastic cells showed an overlap and a likely transitional state between HL and ALCL. Prominent difference of the expression manner of cyclin D 2 could be useful to differentiate HL and ALCL.
出处 《肿瘤防治研究》 CAS CSCD 2004年第6期345-347,共3页 Cancer Research on Prevention and Treatment
关键词 细胞周期素D2 霍奇金淋巴瘤 间变性大细胞淋巴瘤 免疫组化 cyclin D 2 Hodgkin's lymphoma Anaplastic large cell lymphoma Immunohistochemistry
  • 相关文献

参考文献11

  • 1[1]Hunter T, Pines J. Cyclins and cancer II:CyclinD and CDK inhibiters come of age[J]. Cell, 1994, 79(4): 573-582.
  • 2[2]Palmero I, Holder A, Sinclair AJ, et al. cyclins D1 and D2 are differentially expressed in human B-lyphoid cell lines[J]. Oncogene, 1993, 8(4): 1049-1054.
  • 3[3]Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells[J]. Blood, 1985, 66(4): 848-858.
  • 4[4]Stein H, Hummel M. What is the Origin of the Malignant Cell in Hodgkin's Disease?[J].Leukemia and Lymphomas. 1993, 10 (suppl): 99-102.
  • 5[5]Sherr CJ. Cancer cell cycles[J]. Science, 1996, 274(5293): 1672-1677.
  • 6[6]Parada Y, Banerji L, Glassford J, et al. BCR-ABL and interleukin 3 promotes hamatopoietic cell proliferation and survival through modulation of cyclin D2 and p27 kip1 expression[J]. J Bio Chem, 2001, 276(26): 23571-23580.
  • 7[7]Huang Y, Ohtani K, Iwanaga, et al. Direct trans-activation of the human cyclin D2 gene by the oncogene product Tax of human T-cell leukemia virus type I[J]. Oncogene, 2001, 20 (9), 1094-1102.
  • 8[8]Nagasawa M, Melamed I, Kupfer A, et al. Rapid nuclear translocation and increased activity of cyclin-dependent kinase 6 after T cell activation[J]. J Immunol, 1997, 158(11): 5146-5154.
  • 9[9]Delmer A, Ajchenbaum-Cymbalista F, Tang R, et al. Overexpression of cyclin D2 in chronic B-cell malignancies[J]. Blood, 1995, 85(10): 2870-2876.
  • 10[10]Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray[J]. Blood, 2004, 103(1):275-282.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部